Menstrual cycle variation of retroperitoneal lymphangioleiomyomas in lymphangioleiomyomatosis

Internal Medicine Journal

Volumn 41, Issue 12, 2011, Pages 832-835

  Sandrini, A ^a   Silverstone, E ^a   Yates, D H ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Abdominal lymphangioleiomyoma; Female sex hormones; Lymphangioleiomyomatosis

Indexed keywords

ESTROGEN; PROGESTERONE; SMOOTH MUSCLE ACTIN;

ABDOMINAL CRAMP; ABDOMINAL MASS; ABDOMINAL PAIN; ADULT; ARTICLE; BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HORMONE RESPONSE; HUMAN; LAPAROTOMY; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHANGIOLEIOMYOMATOSIS; MELANOSOME; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; NAUSEA; PRIORITY JOURNAL; RETROPERITONEAL TUMOR; STAINING; TUMOR VOLUME; ULTRASOUND;

ADULT; FEMALE; HUMANS; LYMPHANGIOLEIOMYOMATOSIS; LYMPHANGIOMYOMA; MENSTRUAL CYCLE; RETROPERITONEAL SPACE;

EID: 83355177466     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2011.02593.x     Document Type: Article

References (19)

1. Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A 2000; 97: 6085-90.
2. Johnson SR. Lymphangioleiomyomatosis. Eur Respir J 2006; 27: 1056-65.
3. Attili AK, Kazerooni EA. Lymphangioleiomyomatosis. Radiology 2007; 244: 303-6.
4. Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, the ERS LAM Taskforce. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 2010; 35: 14-26.
5. Sandrini A, Krishnan A, Yates DH. Lymphangioleiomyomatosis in Australia [letter]. Am J Respir Crit Care Med 2008; 177: 356.
6. Avila NA, Kelly JA, Chu SC, Dwyer AJ, Moss J. Lymphangioleiomyomatosis: abdominopelvic CT and US findings. Radiology 2000; 216: 147-53.
7. Bernstein SM, Newell JD Jr, Adamczyk D, Mortenson RL, King TE Jr, Lynch DA. How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis? Am J Respir Crit Care Med 1995; 152: 2138-43.
8. Pallisa E, Sanz P, Roman A, Majo J, Andreu J, Caceres J. Lymphangioleiomyomatosis: pulmonary and abdominal findings with pathologic correlation. Radiographics 2002; 22: S185-98.
9. Maziak DE, Kesten S, Rappaport DC, Maurer J. Extrathoracic angiomyolipomas in lymphangioleiomyomatosis. Eur Respir J 1996; 9: 402-5.
10. Matsui K, Tatsuguchi A, Valencia J, Yu Z, Bechtle J, Beasley MB etal. Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases. Hum Pathol 2000; 31: 1242-8.
11. Kamitani T, Yabuuchi H, Soeda H, Matsuo Y, Okafuji T, Sakai S etal. A case of lymphangioleiomyomatosis affecting the supraclavicular lymph nodes. J Comput Assist Tomogr 2006; 30: 279-82.
12. Collins J, Muller NL, Kazerooni EA, McAdams HP, Leung AN, Love RB. Lung transplantation for lymphangioleiomyomatosis: role of imaging in the assessment of complications unrelated to the underlying disease. Radiology 1999; 210: 325-32.
13. Avila NA, Dwyer AJ, Murphy-Johnson DV, Brooks P, Moss J. Sonography of lymphangioleiomyoma in lymphangioleiomyomatosis: demonstration of diurnal variation in lesion size. AJR Am J Roentgenol 2005; 184: 459-64.
14. Avila NA, Bechtle J, Dwyer AJ, Ferrans VJ, Moss J. Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas. Radiology 2001; 221: 415-21.
15. Torres VE, Bjornsson J, King BF, Kumar R, Zincke H, Edell ES etal. Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex. Mayo Clin Proc 1995; 70: 641-8.
16. Sohabib SA, Turner B, Hanson JA, Farquharson M, Oliver RT, Reznek RH. CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol 2000; 73: 1178-284.
17. Matsui K, Takeda K, Yu ZX, Travis WD, Moss J, Ferrans VJ. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis. Arch Pathol Lab Med 2000; 124: 267-75.
18. Zhe X, Yang Y, Jakkaraju S, Schuger L. Tissue inhibitor of metalloproteinase-3 downregulation in lymphangioleiomyomatosis: potential consequence of abnormal serum response factor expression. Am J Respir Cell Mol Biol 2003; 28: 504-11.
19. Eliasson AH, Phillips YY, Tenholder MF. Treatment of lymphangioleiomyomatosis. A meta-analysis. Chest 1989; 96: 1352-5.